Caution is necessary when using selective COX-2 inhibitors in animals with pre-existing gastric ulcers because COX-2 seems to participate in an adaptive cytoprotective mechanism established in the presence of gastric ulcers and accelerates the healing process [21]. The gene discussed is PTGS2; the disease is gastric ulcer.